摘要
川崎病(Kawasaki disease,KD)是5岁以下儿童常见后天获得性心脏病之一,是一种急性全身性血管炎。经过近60年的研究,静脉注射免疫球蛋白(intravenous immunoglobulin,IVIG)联合阿司匹林(aspirin,Asp)口服成为急性期KD预防冠状动脉病变(coronary artery lesion,CAL)的一线治疗。然而,Asp的作用和最佳剂量仍然存在争议。该共识基于KD治疗的国内外最新的研究成果,并经过国内儿科专家充分讨论而制定,对Asp在KD中一线治疗的使用剂量、用法、疗程等提出了推荐意见。
Kawasaki disease(KD)is one of the common acquired heart diseases in children aged<5 years and is an acute systemic vasculitis.After nearly 60 years of research,intravenous immunoglobulin combined with oral aspirin has become the first-line treatment for the prevention of coronary artery lesion in acute KD;however,there are still controversies over the role and optimal dose of aspirin.The consensus was formulated based on the latest research findings of KD treatment in China and overseas and comprehensive discussion of pediatric experts in China and put forward recommendations on the dose,usage,and course of aspirin treatment in the first-line treatment of KD.
作者
陕西省川崎病诊疗中心/陕西省人民医院儿童病院
上海交通大学附属儿童医院
首都医科大学附属北京儿童医院
中国医科大学附属盛京医院
延安大学附属医院
中国妇幼健康研究会儿科能力建设专委会
中国医师协会儿科医师分会普儿科学组
上海合作组织医院合作联盟儿科国际交流合作中心
《中国当代儿科杂志》编辑部
焦富勇
王虹
Shaanxi Province Diagnosis and Treatment Center of Kawasaki Disease/Children's Hospital of Shaanxi Provincial People's Hospital;Children's Hospital of Shanghai Jiao Tong University;Beijing Children's Hospital of Capital Medical University;Shengjing Hospital of China Medical University;Affiliated Hospital of Yan'an University;Expert Committee of Advanced Training for Pediatrician,China Maternal and Children's Health Association;General Pediatric Group of Pediatrician Branch of Chinese Medical Doctor Association;Pediatric International Exchange and Cooperation Center,Shanghai Cooperation Organization Hospital Cooperation Alliance;Editorial Board of Chinese Journal of Contemporary Pediatrics;Jiao F-Y;Wang H
出处
《中国当代儿科杂志》
CAS
CSCD
北大核心
2022年第6期597-603,共7页
Chinese Journal of Contemporary Pediatrics
关键词
川崎病
阿司匹林
专家共识
儿童
Kawasaki disease
Aspirin
Expert consensus
Child
